Skip to content
Dosage GuideResearch Reference

Chonluten Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Chonluten. All information is for educational purposes only.

Quick Answer

Chonluten is a research-grade peptide bioregulator without established human dosing guidelines. Preclinical studies in animal models suggest a dose range of 10–100 mcg for respiratory tissue modulation. Dosage is highly variable depending on the research protocol.

→ Chonluten Benefits→ Chonluten Side Effects→ Full Chonluten Profile
Table of Contents

Standard Dosage Range

Research dosing range: 10–100 mcg (research use only)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Respiratory Epithelium Modulation (preclinical)

10–50 mcg1× daily
Duration

4–8 weeks

Animal studies utilize intraperitoneal or subcutaneous administration. No human data exists; dosages are speculative extrapolations for research purposes only.

Pulmonary Inflammation Reduction (preclinical)

50–100 mcg1× daily
Duration

4–8 weeks

Dosing based on observed anti-inflammatory effects in rodent models. Route of administration is typically IP or SC. Human translational data is lacking.

Respiratory Bioregulation (preclinical)

10-100 mcgmoderate
Duration

moderate

Range reflects doses used in Khavinson's research. No human data available. No therapeutic applications exist.

Timing & Frequency

Timing is not well-defined for Chonluten, given its status as a research peptide. Animal studies typically administer the peptide in the morning. Duration of action is not fully characterized.

Cycle Guidance

No specific cycling guidance exists. Preclinical studies typically utilize a 4–8 week protocol. Any human experimentation should be conducted with extreme caution, given the absence of safety and efficacy data.

Reconstitution Reference

Quick reference for reconstituting Chonluten. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1 mg per vial (research grade)
BAC Water Volume1 mL bacteriostatic water for 1 mg/mL concentration
Concentration & DrawAt 1 mg/mL: 10 mcg = 0.01 mL (1 unit on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 7 days refrigerated. Lyophilized powder stable 12–24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the appropriate human dose of Chonluten?
There is no established or safe human dose for Chonluten. It is strictly a research-grade peptide with limited preclinical data. Any human use is highly discouraged.
How should Chonluten be reconstituted?
Reconstitute with bacteriostatic water. A common concentration is 1 mg/mL, achieved by adding 1 mL of water to a 1 mg vial. Store refrigerated after reconstitution.
Can Chonluten be taken orally?
No data supports oral bioavailability of Chonluten. Preclinical studies utilize injectable routes of administration (IP or SC).

Last updated: 2026-02-19